VAERS reports by lot

Pfizer COVID-19 lot FT1551: VAERS reports

383 VAERS reports list lot FT1551 as a Pfizer COVID-19 vaccine, received between 2022-09-13 and 2023-10-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
383
Reports
1%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2024%
Gastrointestinal1215%
Neurological1113%
Cardiac / Cardiovascular1012%
Respiratory911%
Allergic / Anaphylactic67%
Musculoskeletal67%
Dermatological (non-injection-site)34%
Psychiatric / Neuropsychiatric34%
Thrombotic / Hematological11%
Injection-site / Local reaction11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Colorado56
California49
Texas20
Missouri18
New Jersey18
Georgia15
Michigan14
Illinois13
Wisconsin13
Idaho12
New York10
Washington9

Reports by month received

2022-098
2022-10107
2022-1188
2022-1266
2023-0118
2023-025
2023-0335
2023-0411
2023-058
2023-067
2023-0828
2023-102

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.